EXAM 4 —
EXAM 4 — COMPLETE STUDY NOTES
1. RENAL/GU PATHOPHYSIOLOGY — 5 QUESTIONS
Kidney functions
The kidneys have several major jobs:
1. Blood pressure control
The kidneys help regulate blood pressure through control of:
Fluid volume
Electrolytes
Renal mechanisms involved in BP regulation
2. Erythropoietin production
The kidneys produce erythropoietin, which regulates red blood cell production.
Therefore:
Kidney disease → decreased erythropoietin → decreased RBC production → anemia → pallor/fatigue
3. Filtration and waste removal
The kidneys:
Filter waste products from the blood
Excrete them as urine
When kidney function decreases:
waste products accumulate.
4. Acid-base regulation
The kidneys help maintain normal acid-base balance.
5. Electrolyte regulation
They regulate electrolytes such as:
Sodium
Potassium
Calcium
Phosphate
6. Water/fluid balance
The kidneys determine how much water is retained versus excreted.
Kidney dysfunction can therefore cause:
fluid retention → edema → weight gain
7. Vitamin D activation
The kidneys synthesize vitamin D into its active form.
This is important for calcium/phosphate balance and bone health. Week 8- Renal and GU(4)
RENAL DISEASE RISK FACTORS
Your lecture identifies:
Diabetes mellitus
Hypertension
Increasing age
Family history
Glomerulonephritis
Medication use
NSAIDs
Antibiotics
Obesity
Polycystic kidney disease
Pyelonephritis
Smoking
Urinary obstruction
Tumors
Enlarged prostate
Stones
POLYCYSTIC KIDNEY DISEASE
PKD = fluid-filled cysts develop in the kidneys.
The cysts can interfere with normal kidney function.
Possible manifestations/complications:
Pain
Infection
Hypertension
Progressive renal failure
PYELONEPHRITIS
Pyelonephritis = kidney infection.
The lecture says it is usually caused by E. coli ascending from the bladder.
A urinary catheter increases risk.
If untreated:
kidney infection → chronic kidney damage
GLOMERULOPATHIES
Glomerular disease can impair filtration.
Expected findings:
Proteinuria
↓ GFR
Edema
Hypertension
It can progress to:
ESRD/end-stage renal disease.
NEPHROTIC SYNDROME
Important concept:
Massive protein loss
→ decreased protein in blood
→ fluid moves into tissues
→ edema
Associated with:
Massive protein loss
Edema
Hypertension
Progression toward ESRD
RENAL CALCULI
Renal calculi = kidney stones.
The lecture says they are often calcium-based.
Risk factors
Hypertension
High-protein intake
High-sodium intake
Immobility
Family history
Hyperparathyroidism
Major manifestation
Severe flank pain/renal colic
Prevention
The lecture emphasizes:
2–3 L fluid/day
Limit sodium
Limit protein
Avoid excessive calcium supplements
AKI — ACUTE KIDNEY INJURY
AKI = sudden reduction in kidney function.
It results from an insult to the nephron.
The lecture describes:
Altered laboratory values
Decreased urine output
There are three categories.
PRE-RENAL AKI
The problem occurs before the kidney:
decreased blood flow/perfusion to the kidneys
Examples:
Burns
Hemorrhage
Hypovolemic shock
Prolonged vomiting
Prolonged diarrhea
Think:
Not enough blood getting to the kidneys.
INTRA-RENAL AKI
The kidney tissue itself is damaged.
Examples:
Nephrotoxic medications
Aminoglycosides
Contrast media
Prolonged ischemia
Think:
Actual kidney tissue injury.
POST-RENAL AKI
The problem occurs after the kidney:
urine outflow is blocked.
Examples:
BPH
Blood clots
Renal stones
Tumors
Think:
Urine can't get out.
CKD — CHRONIC KIDNEY DISEASE
CKD is:
Progressive and irreversible loss of kidney function over months to years.
As functioning nephrons are lost:
↓ GFR
Therefore the kidneys become less able to:
Remove waste
Regulate electrolytes
Maintain acid-base balance
Control fluid volume
Control BP
What happens to remaining nephrons?
Remaining nephrons initially compensate through:
hyperfiltration
This temporarily helps maintain GFR.
But eventually:
hyperfiltration → additional nephron damage → further kidney-function loss.
Two major consequences to remember
↓ erythropoietin
→ anemia
↓ vitamin D activation
→ calcium/phosphorus imbalance
→ bone demineralization
→ renal osteodystrophy
The lecture also describes inflammatory-cell infiltration, activation/loss of renal cells, extracellular-matrix production, and fibrosis/scarring as part of progressive CKD damage.
2. RENAL/GU CLINICAL SIGNS — 5 QUESTIONS
The blueprint specifically wants:
Fluid imbalance
Edema
Weight changes
BP variations
Altered mental status
Urinary incontinence 2302 Exam 4 Blueprint -1
DAILY WEIGHTS
The most sensitive indicator of fluid balance.
Important number:
1 kg = 2.2 lb ≈ 1 liter of fluid
Daily weight is considered more reliable than I&O alone.
Example
If a patient gains:
2.2 lb overnight
that corresponds approximately to:
1 L of fluid gain.
SKIN/MUCOUS MEMBRANES IN RENAL DISEASE
Assess for:
Edema
Fluid accumulation in tissues.
Uremic frost
Rare, severe finding.
Pruritus
Itching.
Pallor
Related to:
↓ erythropoietin → anemia
Dry skin / poor turgor
Can indicate altered fluid status.
NEUROLOGICAL FINDINGS
Uremia can affect the brain.
Look for:
Confusion
Lethargy
Difficulty concentrating
Asterixis
Asterixis
An advanced neurological finding associated with uremia.
URINARY INCONTINENCE
There are several types.
URGE INCONTINENCE
The patient suddenly feels a strong urge to urinate and may not make it to the bathroom.
Associated with:
overactive detrusor muscle.
Possible associated conditions:
Urinary infection
BPH obstruction
Parkinson disease
MS
Stroke
STRESS INCONTINENCE
Urine leaks when intra-abdominal pressure increases.
Examples:
Coughing
Sneezing
Bending
Related to loss of pelvic muscle support.
Risk factors listed in lecture include:
Estrogen depletion
Obesity
Childbirth trauma
Cancer therapy
Spinal nerve damage from diabetes
MIXED INCONTINENCE
Combination of:
urge + stress
OVERFLOW INCONTINENCE
The bladder doesn't empty completely.
→ residual urine
→ urinary stasis
→ increased infection risk.
Common in:
older adult males with BPH.
FUNCTIONAL INCONTINENCE
The urinary system itself is intact.
The problem is something else prevents the person from reaching/responding to the toilet in time.
Example:
Immobility.
URINARY TERMINOLOGY
Anuria
<50 mL urine/24 hours
Dysuria
Painful or difficult urination.
Oliguria
Reduced urine output.
May indicate:
Dehydration
Fluid retention
Decreasing kidney function
Urinary frequency
Urination multiple times during the day/night.
Urgency
A compelling need to urinate.
Nocturia
Nighttime urination.
Polyuria
>2.5 L/24 hours
3. FOCUSED RENAL/GU ASSESSMENT — 2 QUESTIONS
BLADDER ASSESSMENT
Palpate the:
suprapubic area
to assess for:
bladder distention.
Empty bladder
Not normally palpable.
Mildly full bladder
Slightly firm
Nontender
Below umbilicus
Full bladder
Firm
May extend above umbilicus
CVA TENDERNESS
Assess the:
costovertebral angle (CVA).
Pain/tenderness can indicate:
kidney involvement.
Adult kidneys
Normally:
not palpable.
URINE ASSESSMENT
Assess:
Color
Pale yellow
Dark
Amber
Red
Cloudy
Clarity
Clear
Cloudy
Odor
Strong
Foul
Sweet
Amount
Normal adult output:
≥30 mL/hr
Also assess for:
Sediment
Mucus
Blood
I&O
Monitor:
Intake
Output
Intake vs output
Trends over time
Pay particular attention to:
Oliguria
Anuria
Postoperative patients
CHF patients
4. RENAL/GU MEDICATIONS — 5 QUESTIONS
OXYBUTYNIN — DITROPAN
Class
Anticholinergic.
What does it do?
Normally acetylcholine binds to M3 receptors in the bladder and causes the detrusor muscle to contract.
Oxybutynin:
blocks M3 receptors
→ decreases detrusor contractions
→ increases bladder capacity
→ decreases urgency
→ decreases frequency
→ decreases urge incontinence.
Used for
Overactive bladder / urinary incontinence.
Adverse effects
Because it blocks acetylcholine, think:
“everything dries up.”
The lecture specifically lists:
Mydriasis/dilated pupils
Drowsiness
Confusion
Anticholinergic effects
Nursing considerations
Monitor:
Anticholinergic effects
I&O
Bladder distention
Because it can increase intraocular pressure:
eye examinations are important.
Safety
Do not give with:
Glaucoma
GU obstruction
GI obstruction
Week 8- Renal and GU(4)
BETHANECHOL — URECHOLINE
Class
Cholinergic.
Opposite of oxybutynin
Bethanechol:
stimulates acetylcholine
→ stimulates muscarinic receptors
→ bladder contracts
→ sphincter relaxes
→ promotes urination.
Used for
Urinary retention
Specifically:
Acute postoperative nonobstructive retention
Postpartum nonobstructive retention
Neurogenic bladder with retention
Adverse effects
Cholinergic effects:
Increased salivation
Increased gastric acid secretion
Vasodilation
Hypotension
Fainting
Bronchospasm
Diarrhea
Nursing
Monitor:
Vital signs
Respiratory status
Postural hypotension
Report:
Shortness of breath
Bronchospasm
The patient may urinate frequently.
Lecture teaching:
Increase fluid intake to compensate.
Major interaction
Do not give with cholinesterase inhibitors.
Why?
Both increase acetylcholine.
→ excessive cholinergic effect. Week 8- Renal and GU(4)
PHENAZOPYRIDINE
Class
Urinary analgesic.
Action
Provides local analgesic action on the urinary tract mucosa.
Used for
Relief of:
Urinary pain
Burning
Frequency
Urgency
Irritation of urinary tract mucosa
EXPECTED EFFECT
Urine may become:
reddish-orange.
Saliva and tears can also become reddish-orange.
This is an expected medication effect.
Before giving
Assess:
Renal function
Liver function
because toxicity can occur in patients with renal/hepatic insufficiency.
Patient should NOT:
Take extra doses
Wear contact lenses
Drink alcohol
Take it longer than 2 days
Why not longer than 2 days?
It could mask symptoms of a bacterial infection that isn't resolving.
Week 8- Renal and GU(4)
DIURETICS
Used for:
Fluid overload
BP control
Common in:
CHF + renal overlap
Important kidney consideration
Diuretics can cause/worsen:
pre-renal AKI if overused
because excessive fluid removal can decrease renal perfusion.
ACE INHIBITORS / ARBs
Examples:
Lisinopril
Losartan
Purpose
Can protect the kidneys in:
Diabetes
Hypertension
Important effects
Decrease intraglomerular pressure.
Watch for
Increased creatinine initially
Hyperkalemia
HYPERKALEMIA MEDICATIONS
Lecture lists:
Sodium bicarbonate
Used in hyperkalemia management.
Calcium gluconate
Used in hyperkalemia management.
Insulin + dextrose
Used in hyperkalemia management.
Sodium polystyrene
Used to help manage elevated potassium.
Critical concept
Hyperkalemia can be life-threatening.
CALCIUM CARBONATE
Purpose
Used as a phosphate binder.
Helps prevent:
hyperphosphatemia
and associated bone disease.
Key administration point
Take with meals.
WEEK 9 — ENDOCRINE
15 questions
1. ENDOCRINE PATHOPHYSIOLOGY — 5 QUESTIONS
The blueprint specifically requires:
Thyroid
Parathyroid
Pituitary
Adrenal
Hormone regulation/feedback
Hyperthyroidism
Hypothyroidism
Hyperparathyroidism
Hypoparathyroidism
DI
SIADH
Addison's
Cushing's 2302 Exam 4 Blueprint -1
THYROID HORMONES
T4 — THYROXINE
Contains:
4 iodine atoms
It is the:
more abundant thyroid hormone.
T3 — TRIIODOTHYRONINE
Contains:
3 iodine atoms
It is:
more active.
TSH
Produced by:
anterior pituitary
TSH stimulates the thyroid to:
Produce thyroid hormones
Release T3/T4
Increase metabolic activity
CALCITONIN
Produced by:
parafollicular/C cells of thyroid
Released when:
calcium is high.
Effects:
Inhibits osteoclasts
Increases calcium excretion
Lowers serum calcium
IODINE DEFICIENCY
Iodine is needed for T3/T4 production.
↓ iodine
→ ↓ T3/T4
→ ↑ TSH
→ thyroid stimulation/enlargement
→ goiter
The lecture identifies iodine deficiency as the most common worldwide cause of goiter.
HYPERTHYROIDISM
Problem
Overproduction of T3/T4
Most common cause
Graves disease
Why symptoms happen
Thyroid hormone increases metabolic activity.
Therefore expect:
Weight loss
Heat intolerance
Sweating
Tachycardia
Diarrhea
Fine tremors
Mood changes
Weakness
GRAVES DISEASE
Autoimmune disorder.
Antibodies such as:
TRAb/TSI
stimulate thyroid follicular cells.
→ excessive T3/T4 production
→ goiter
Can also cause:
exophthalmos.
Complications
Arrhythmias
Heart failure
Miscarriage
Preterm birth
Preeclampsia
Osteoporosis
Thyroid storm
THYROID STORM
A life-threatening extreme increase in thyroid hormone activity.
Potential triggers include:
Infection
Trauma
Abrupt discontinuation of antithyroid medication
Acute illness
Stroke
Childbirth
Inadequately treated hyperthyroidism
After thyroid removal
Findings
Severe tachycardia
Fever
Dehydration
Heart failure
Confusion/delirium
Nausea/vomiting
Diarrhea
Agitation/anxiety
Shakiness
Jaundice
Loss of consciousness
Can progress to:
Clots
Heart failure
Seizures
Delirium
Coma
HYPOTHYROIDISM
Problem
Inadequate T3/T4
Most common cause
Hashimoto thyroiditis
Findings
Think of metabolism slowing down:
Bradycardia
Cold intolerance
Constipation
Fatigue
Weight gain
Goiter
HASHIMOTO THYROIDITIS
Autoimmune destruction of thyroid tissue.
Antibodies/T-cell activity:
→ destruction of thyroid follicular cells
→ fibrosis
→ decreased thyroid hormone secretion.
MYXEDEMA COMA
Severe complication of untreated hypothyroidism.
Can cause:
Hypothermia
Cardiovascular collapse
Hypoventilation
Hyponatremia
Hypoglycemia
Lactic acidosis
Coma
PARATHYROID
There are:
4 parathyroid glands
near the thyroid.
They produce:
PTH — parathyroid hormone
PTH works with:
Vitamin D3
Calcitonin
to regulate calcium.
PTH targets:
Kidneys
Skeleton
Intestines
HYPOPARATHYROIDISM
Problem
Insufficient PTH
→ dangerously low calcium
Because calcium and phosphate have an inverse relationship:
↓ calcium → ↑ phosphate
Causes
Autoimmune disease
Idiopathic disease
Thyroid/parathyroid surgery
Findings
Tetany
Paresthesia
Prolonged QT
Chvostek sign
Trousseau sign
Treatment can include:
IV calcium gluconate
Oral calcium
Vitamin D supplements Week 9 PPT
CHVOSTEK SIGN
Tap the facial nerve.
Positive:
involuntary twitching of facial muscles.
Indicates:
nerve hyperexcitability associated with hypocalcemia.
TROUSSEAU SIGN
Inflate BP cuff above systolic pressure for approximately:
3 minutes
Positive:
hand spasm/carpopedal spasm.
Also indicates:
hypocalcemia/neuromuscular excitability.
PITUITARY
Known as the:
“master gland.”
Anterior pituitary
Produces hormones involved in:
Growth/development
Metabolism
Reproduction
Stress
Posterior pituitary
Stores/releases:
Oxytocin
ADH/vasopressin
ADH
ADH regulates:
water balance.
It causes the kidneys to:
reabsorb water.
Therefore:
More ADH → more water retained
Less ADH → more water lost in urine
DIABETES INSIPIDUS
Problem
Chronic underproduction of ADH OR mutation in the ADH receptor.
→ kidneys cannot retain water.
→ large amounts of water lost in urine.
Major findings
Polyuria >3 L/24 hr
Polydipsia
Dehydration
Hypernatremia
Fatigue
Hypotension
Tachycardia
Dizziness
Weakness
Possible loss of consciousness
Hypovolemic shock
Labs
↓ urine osmolality
↑ serum osmolality
Serum sodium assessed
Treatment
Treat underlying cause
Maintain fluid intake
Desmopressin
Vasopressin Week 9 PPT
SIADH
Problem
Too much/unsuppressed ADH
→ kidneys retain excessive water
→ hypervolemia
→ dilutional hyponatremia
Causes listed
Certain cancers
CNS disturbances
Certain medications
Pulmonary disease
Vascular disease
MI
Sometimes hereditary
Early findings
Malaise
Nausea
Vomiting
As sodium falls:
Lethargy
Headache
Obtundation
Seizures
Coma
Respiratory arrest
Critical sodium
<120 mEq/L → coma/respiratory arrest
Labs
↓ serum osmolality
↓ serum sodium
↑ urine sodium
Treatment
Treat underlying cause
Fluid restriction
Sodium chloride
Loop diuretics such as furosemide
Hypertonic saline for severe symptoms
Demeclocycline
Tolvaptan
The lecture emphasizes careful sodium monitoring because correcting sodium too rapidly can cause permanent brain injury. Week 9 PPT
ADRENAL GLANDS — ADDISON'S
Addison's disease
Autoimmune adrenal insufficiency.
Antibodies attack adrenal tissue.
→ decreased cortisol and aldosterone production.
Findings
Fatigue
Weight loss
Weakness
Abdominal pain
Nausea/vomiting
Dizziness
Hyperpigmentation
ADRENAL CRISIS
Also called:
Addisonian crisis
Rapid onset and emergency.
Can be triggered by:
Abrupt steroid discontinuation
Inadequate steroid dosing
Infection
Trauma
Findings
Nausea
Vomiting
Abdominal pain
Hypotension
Altered mental status
Obtundation
Shock
Initial treatment
IV fluids
Dextrose
Hydrocortisone
Lecture gives approximately:
25% mortality. Week 9 PPT
CUSHING'S SYNDROME
Problem
Excess cortisol exposure over a long period.
Effects
Excess cortisol:
→ ↑ gluconeogenesis
→ insulin resistance
→ altered metabolism of glycogen/fats
→ impaired protein synthesis
→ poor wound healing
→ osteoporosis
→ poor immune function.
Most common cause
Long-term/high-dose glucocorticoid use
Cushing disease
A pituitary tumor/adenoma:
→ ↑ ACTH
→ adrenal glands produce ↑ cortisol.
Diagnostics
Dexamethasone suppression test
24-hour urine free cortisol
Serum electrolytes
Fasting blood glucose
Possible labs:
Hypokalemia
Hypocalcemia
Elevated fasting glucose
Treatment
Depends on cause.
May include:
Gradual steroid taper for exogenous Cushing's
Mifepristone
Adrenal surgery
Hypophysectomy
Radiation
Bilateral adrenalectomy
Bisphosphonates
Potassium
Diuretics
Antihypertensives
2. ENDOCRINE ASSESSMENT — 5 QUESTIONS
Hyperthyroidism
Expect:
Weight loss
Heat intolerance
Sweating
Tachycardia
Tremors
Diarrhea
Mood changes
Weakness
Hypothyroidism
Expect:
Weight gain
Bradycardia
Cold intolerance
Constipation
Fatigue
Goiter
Hypoparathyroidism
Think:
LOW calcium
Look for:
Tetany
Paresthesia
Prolonged QT
Chvostek
Trousseau
DI
Think:
LOW ADH → LOTS OF WATER LOST
Polyuria
Polydipsia
Dehydration
Hypernatremia
Hypotension
Tachycardia
SIADH
Think:
HIGH ADH → TOO MUCH WATER RETAINED
Fluid excess
Hyponatremia
↓ serum osmolality
↑ urine sodium
Neurological changes
Addison's
Weight loss
Weakness
Fatigue
Hypotension/dizziness
Hyperpigmentation
N/V
Abdominal pain
Cushing's
Excess cortisol
Hyperglycemia
Hypokalemia
Hypocalcemia
Poor wound healing
Osteoporosis
Poor immunity
Fluid-volume concerns
3. ENDOCRINE MEDICATIONS — 5 QUESTIONS
METHIMAZOLE
Action
Inhibits thyroid hormone synthesis
→ decreases thyroid hormone levels
→ decreases hyperthyroid manifestations.
Indication
Hyperthyroidism
Adverse effects
Agranulocytosis
Thrombocytopenia
Aplastic anemia
Fever
Hypoglycemia
Jaundice
Urticaria
Epigastric distress
Arthralgia
Nursing
Monitor:
CBC
Coagulation studies
Liver function
Thyroid levels
Patient teaching
Take as prescribed.
Monitor weight weekly.
Report:
Sore throat
Skin eruptions
Fever
Headache
Malaise
The lecture says to report weight gain of:
3 lb/24 hr or 5 lb/week
Precautions/interactions
Liver dysfunction
Anticoagulants
Beta blockers
Digitalis
Theophylline
Lecture also says:
Avoid dietary iodine and avoid pregnancy. Week 9 PPT
LEVOTHYROXINE
Action
Thyroid hormone replacement.
Replaces deficient thyroid hormone.
Indication
Hypothyroidism
TSH suppression in specified pituitary conditions
Adverse effects
Irregular heartbeat
Heat intolerance
Irregular breathing
Irritability
Nausea/vomiting
Tremors
Decreased urine output
Nursing
Monitor:
thyroid levels
Therapy is generally:
lifelong
Administration
Take:
in the morning on an empty stomach
At least:
30 minutes before food/caffeine
Separate from:
Calcium
Iron
by at least:
4 hours
Contraindication
Untreated adrenal insufficiency
CALCIUM CARBONATE
Action
Acts in the small intestine and helps increase circulating ionized calcium while reducing serum phosphate.
Indications
Hypocalcemia
Phosphate reduction/binding
Antacid use
Adverse effects
Upset stomach
Vomiting
Abdominal pain
Bloating
Constipation
Dry mouth
Loss of appetite
Metallic taste
Increased urination
Kidney stones
Hypercalcemia can produce:
Fatigue
Confusion
Constipation
Increased thirst
Frequent urination
Nursing
Monitor:
Calcium
Vitamin D
Phosphate
PTH
Thyroid hormones
Teaching
Eat foods high in:
Calcium
Vitamin D
Take exactly as prescribed.
Interactions
Calcium can interfere with absorption of:
Tetracyclines
Bisphosphonates
Thyroid hormone replacements
These should be separated in administration time.
Contraindications/precautions
Hypersensitivity
Hypercalcemia
Kidney stones
Malabsorption disorders Week 9 PPT
CALCITRIOL
What it is
An activated vitamin D preparation.
Vitamin D promotes:
Calcium absorption
Phosphorus absorption
Maintenance of calcium/phosphate levels
Indications
The lecture identifies calcitriol for:
Hypocalcemia
Hypoparathyroidism
Adverse effects
Constipation
Dry mouth
Bone pain
Metallic taste
Polyuria
Pruritus
Increased AST
Increased BUN
Contraindications
Hypercalcemia
Vitamin D toxicity
Hypersensitivity
Malabsorption disorders
Vitamin D toxicity may produce:
Recurrent vomiting
Confusion
Apathy
Dehydration
CINACALCET
Class
Calcimimetic.
Action
Amplifies the:
calcium-sensing receptor (CaSR)
→ suppresses PTH
→ decreases blood calcium.
Indications
Primary hyperparathyroidism
Secondary hyperparathyroidism
Hypercalcemia
Adverse effects
Nausea/vomiting
Abdominal pain
Muscle cramps
Bone pain
Increased fracture risk
Nursing
Monitor:
Calcium
Vitamin D
Phosphate
PTH
Thyroid hormones
Administration
Take:
with meals
Tablet should not be:
Chewed
Crushed
Divided
Caution
Use cautiously with:
Severe liver impairment
Upper GI bleeding
Hypotension
Heart failure
Bone disease
ALENDRONATE
Class
Bisphosphonate.
Action
Attaches to bone/hydroxyapatite binding sites.
When osteoclasts attempt to resorb bone:
→ alendronate interferes with osteoclast activity
→ ↓ bone resorption
→ ↑ bone density.
Indication
Prevention and treatment of osteoporosis
Adverse effects
GI discomfort
Nausea
Esophageal irritation
Musculoskeletal pain
Bone pain
Osteonecrosis of jaw
Atypical fractures
VERY IMPORTANT ADMINISTRATION
Take with water.
Remain:
upright for at least 30–60 minutes
This reduces esophageal irritation.
Contraindications
Esophageal disorders
Unable to remain upright
Hypocalcemia
Hypersensitivity
VASOPRESSIN
What is it?
ADH.
Action
Binds vasopressin receptors in the kidney.
→ increases water reabsorption
→ decreases water lost in urine
→ helps prevent dehydration.
It also causes:
vasoconstriction
→ increases BP.
Uses in lecture
Shock
Cardiac arrest
ADH-related disorders
Adverse effects
Lecture table lists:
Bradycardia
Increased bilirubin
Hyponatremia
Ischemic lesions
Decreased platelets
Nursing
Monitor:
I&O
Sodium
Other electrolytes
Urine specific gravity
Fluid excess
Watch for:
water intoxication/fluid excess
including:
Nausea/vomiting
Headache
Mental-status changes
Muscle cramps
Drowsiness
Also watch for fluid loss:
Extreme thirst
Dry mouth
Fatigue
Teaching
Journal symptoms
Monitor I&O
Report concerning symptoms
Do not stop unless directed
DEMECLOCYCLINE
Action
Interferes with vasopressin
→ regulates water balance
→ increases urine output
→ decreases excess water.
Indication
SIADH
Adverse effects
Nausea
Vomiting
Diarrhea
Photosensitivity
Nursing
Monitor:
I&O
Electrolytes
Sodium
Urine specific gravity
Watch for fluid overload.
Teaching
Report:
sudden weight gain
because this can indicate fluid overload.
Contraindication
Hypersensitivity. Week 9 PPT
METHYLPREDNISOLONE
Class
Glucocorticoid.
Action
Binds glucocorticoid receptors.
→ decreases inflammatory molecules
→ inhibits immune response
→ decreases inflammation.
Effects
Anti-inflammatory
Immunosuppressive
Adverse effects
Weight gain
Hypertension
Osteoporosis
Increased infection risk
Skin atrophy
Hyperglycemia/glycosuria
Nursing
Monitor:
Vital signs
Sodium
Potassium
BUN
Creatinine
Glucose
Aldosterone
Cortisol
Bone density
Assess for:
fluid-volume excess
Teaching
Take as prescribed
Avoid people who are sick
Report infection
Report edema
Report weight gain >2 lb in 3 days or 5 lb/week
Limit salt
Do NOT stop abruptly
Contraindications/precautions
Hypersensitivity
Systemic active fungal infections
FLUDROCORTISONE
Class
Mineralocorticoid.
Action
Binds mineralocorticoid receptors in kidneys.
→ increases sodium reabsorption
→ increases potassium excretion
→ regulates fluid/electrolyte balance.
Indication
Primary/secondary adrenal insufficiency in:
Addison's disease
Adverse effects
Edema
Cardiac enlargement
Potassium loss
Muscle weakness
Abdominal distention
Impaired wound healing
Growth suppression
Hyperglycemia
Urticaria
Hypertension/hypokalemia
Nursing
Monitor:
Vital signs
Sodium
Potassium
BUN
Creatinine
Glucose
Aldosterone
Cortisol
Bone density
Assess for:
fluid-volume excess
Teaching
Avoid sick people
Report edema
Report weight gain >2 lb/3 days or 5 lb/week
Limit salt
Report infection
Do not stop abruptly
Contraindications/precautions
Systemic fungal infection
Hypersensitivity
May mask infection Week 9 PPT
WEEK 10 — DIABETES
16 questions
1. RISK FACTORS + PATHOPHYSIOLOGY — 3 QUESTIONS
INSULIN
Insulin is produced by:
β cells of the pancreatic islets of Langerhans.
After eating:
Carbohydrates → glucose → blood glucose rises
→ pancreas releases insulin
→ insulin allows:
Muscle cells
Fat cells
Liver cells
to absorb glucose.
Result
Blood glucose decreases.
Insulin also participates in:
Lipid metabolism
Protein metabolism
Anti-inflammatory effects 2302 week 10 Diabetes
GLUCAGON
Produced by:
α cells of pancreas.
When blood glucose is low:
glucagon stimulates:
glycogen breakdown in the liver
→ glucose enters bloodstream
→ blood glucose increases.
TYPE 1 DIABETES
Autoimmune destruction of:
β cells
→ pancreas stops producing insulin.
Without insulin:
glucose can't enter cells normally
→ blood glucose rises.
Patients require:
lifelong insulin.
Risk factors
Young age
Family history
Certain viral infections
Clinical manifestations
Weight loss
High blood glucose
Acute onset
Polydipsia
Polyphagia
Polyuria
TYPE 2 DIABETES
The body:
Doesn't produce enough insulin
Or doesn't use insulin effectively
→ insulin resistance
β cells retain some insulin-producing ability.
Risk factors
Prediabetes
Obesity
Age ≥45
Family history
Sedentary lifestyle
Fatty liver
History of gestational diabetes
Clinical manifestations
Symptoms develop more slowly.
Fatigue
Frequent infections
High blood glucose
GESTATIONAL DIABETES
Pregnancy increases insulin demands.
β cells cannot adequately compensate.
→ reduced insulin sensitivity
→ hyperglycemia.
The lecture says it affects up to:
14% of pregnancies.
Usually returns to normal after pregnancy, but increases future risk of:
Type 2 diabetes. 2302 week 10 Diabetes
2. HYPOGLYCEMIA VS HYPERGLYCEMIA — 2 QUESTIONS
HYPERGLYCEMIA
Lecture defines:
>110 mg/dL
Why it happens
Too little insulin or too much insulin resistance.
Findings
Polyuria
Polydipsia
Polyphagia
Blurred vision
Restlessness
Unintentional weight loss
Abdominal pain
Vomiting
Drowsiness
Hot/dry skin
Hypotension
Coma
Severe hyperglycemia can lead to:
DKA → coma → death
2302 week 10 Diabetes
HYPOGLYCEMIA
Think:
The brain/body isn't getting enough glucose.
Findings:
Tremors/shakiness
Nervousness/anxiety
Sweating
Chills
Clamminess
Irritability
Mood swings
Confusion
Tachycardia
Dizziness
Lightheadedness
Hunger
Nausea
Pallor
Sleepiness
Weakness
Fatigue
Blurred/impaired vision
Tingling/numbness of lips/tongue/cheeks
Headache
Coordination problems
Irregular heart rate
2302 week 10 Diabetes
3. NURSING ASSESSMENT — 2 QUESTIONS
General survey
Assess:
Appearance
Body habitus
Level of consciousness
Orientation
Look for:
Fatigue
Weight changes
Confusion
Diaphoresis
Vital signs
Assess:
BP
HR
RR
Temperature
O₂ saturation
Look for:
Hypertension
Tachycardia
Fever
Kussmaul respirations
BLOOD GLUCOSE
Assess:
Capillary glucose
Trends
Timing
Determine whether the patient is experiencing:
hypoglycemia or hyperglycemia.
METABOLIC ASSESSMENT
Assess:
A1C
Ketones
Symptoms
RESPIRATORY ASSESSMENT
Assess:
Rate
Depth
Effort
Important finding
Deep, rapid breathing → possible DKA
This is:
Kussmaul respirations.
SUBJECTIVE ASSESSMENT
Ask about:
Obesity history
Diabetes history
Unplanned weight loss
Neuropathic pain
Polyuria
Polydipsia
PHYSICAL FINDINGS
Possible:
Decreased touch sensation
Decreased temperature sensation
Blurred vision
Hypertension
Kussmaul respirations
Loss of ankle deep-tendon reflexes
Weak dorsalis pedis pulses
Weak posterior tibial pulses
Dry skin
Muscle atrophy
Foot ulceration
Obesity
Candida infection
Thick hyperpigmentation under skin folds
Poor skin turgor
MEDICATION ASSESSMENT
Assess:
Insulin/oral medications
Dose
Timing
Adherence
Look for:
Missed doses
Frequent hypoglycemia
INSULIN INJECTION ASSESSMENT
Assess:
Site rotation
Storage
Administration technique
Look for:
Lipohypertrophy
and poor injection technique.
NUTRITION
Assess:
Meal timing
Carbohydrate intake
Appetite
Look for:
Inconsistent meals
Poor intake
GI
Assess:
Nausea
Vomiting
Abdominal pain
Important:
Vomiting → possible DKA
RENAL/GU
Assess:
Urine output
Frequency
Nocturia
Look for:
Polyuria
Dehydration
UTI
FLUID STATUS
Assess:
I&O
Edema
Look for:
Dehydration
Dependent edema
4. DIABETES COMPLICATIONS — 2 QUESTIONS
MICROVASCULAR
Retinopathy
→ vision damage
→ blindness
Neuropathy
→ nerve damage
→ pain/numbness/tingling
Nephropathy
→ kidney damage
→ possible ESRD.
MACROVASCULAR
Diabetes damages blood vessels and increases risk of:
Cardiovascular disease
MI
Stroke
Peripheral vascular disease
OTHER COMPLICATIONS
ESRD
Amputation
Hypoglycemia
Gastroparesis
Increased infection/sepsis risk
Foot ulcers
DKA
Usually associated with:
Type 1 diabetes
Development
Can occur:
within 24 hours
Triggers
Infection
Sepsis
Stress
Missed insulin
Pathophysiology
Not enough insulin
→ body can't use glucose normally
→ begins breaking down lipids
→ lipids produce:
ketones
→ ketoacidosis.
HHS
Usually associated with:
Type 2 diabetes
Development
Days to weeks
Common trigger
Illness
Infection
Pathophysiology
Severe/chronic hyperglycemia
→ severe dehydration
→ weakness
→ confusion
Lecture gives mortality as:
up to 20%.
5. DIABETES MEDICATIONS — 3 QUESTIONS
INSULIN
Therapeutic effect
Decreases blood glucose.
Insulin promotes:
glucose uptake by cells.
Major adverse effect
HYPOGLYCEMIA
Other adverse effects listed:
Weakness
Headache
Nausea
Diarrhea
Abdominal pain
Cough
Weight gain
Edema
Injection-site irritation/reaction
Lipodystrophy
Major nursing point
Hypoglycemia risk increases when insulin reaches:
peak time
because peak = maximum glucose-lowering effect.
INSULIN SAFETY
The lecture specifically calls for:
independent double checks.
Double-check:
Client identifiers
Insulin type
Product
Dose
Measured dose
Especially important when the patient receives:
more than one type of insulin.
Administration
Use:
insulin syringes
for insulin administration. 2302 week 10 Diabetes
RAPID-ACTING INSULIN
Examples:
Aspart — Novolog
Glulisine — Apidra
Lispro — Humalog
Onset
15–30 minutes
Peak
1–2 hours
Duration
2–4 hours
Meal timing
Take:
15 minutes before meal OR immediately after meal
Often combined with longer-acting insulin.
SHORT-ACTING INSULIN
Example:
Regular insulin
Humulin R
Novolin R
Onset
30 min–1 hr
Peak
2–3 hr
Duration
3–6 hr
Meal timing
30–60 minutes before meal
INTERMEDIATE-ACTING INSULIN
Example:
NPH/isophane
Humulin N
Novolin N
Onset
2–4 hours
Peak
4–12 hours
Duration
12–18 hours
Often provides coverage:
12 hours or longer/overnight.
LONG-ACTING INSULIN
Examples:
Degludec — Tresiba
Detemir — Levemir
Glargine — Lantus
Onset
1–2 hours
Peak
Does not peak
Duration
Up to 24 hours
Provides coverage for approximately the entire day.
INSULIN APPEARANCE
Most insulin:
clear
Exception:
NPH = cloudy
2302 week 10 Diabetes
GLIPIZIDE
Class
Sulfonylurea
Administration
Time with meals
Peak
1–3 hours
Major adverse effect
Hypoglycemia
Important interaction
Hypoglycemia can be potentiated by:
NSAIDs
Other highly protein-bound drugs
METFORMIN
Class
Biguanide
Major nursing concern
Lactic acidosis
Contraindications
Renal disease
Hepatic disease
Contrast studies
Temporarily discontinue for radiologic studies involving:
intravascular iodinated contrast.
Stop immediately if
Signs of lactic acidosis occur or the patient develops a condition associated with:
Hypoxemia
Dehydration
Sepsis
Common adverse effects
Diarrhea
Nausea/vomiting
Weakness
Flatulence
Indigestion
Abdominal discomfort
Headache
SITAGLIPTIN
Class
DPP-IV inhibitor
Administration
Can be taken:
with or without food.
Adverse effects/concerns
Hypoglycemia
Hypersensitivity reactions
Blisters/erosions
Headache
Pancreatitis symptoms
Heart failure
Severe arthralgia
Upper-respiratory infection
2302 week 10 Diabetes
GLUCAGON
Class
Hypoglycemia treatment.
Action
Increases blood glucose by:
stimulating glycogen breakdown in the liver.
Peak
15 minutes
Forms
Injectable
Nasal spray
When used
When the patient is:
Semiconscious
Unconscious
Unable to ingest sugar-containing food
Nursing
After administration:
Reassess blood glucose in 15 minutes.
Adverse effects
Nausea
Vomiting
Temporary tachycardia
Contraindications
Hypersensitivity
Pheochromocytoma